about
Automatic flow injection based methodologies for determination of scavenging capacity against biologically relevant reactive species of oxygen and nitrogen.Drug-membrane interactions: significance for medicinal chemistry.Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions.Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells.Tunable pDNA/DODAB:MO lipoplexes: the effect of incubation temperature on pDNA/DODAB:MO lipoplexes structure and transfection efficiency.Structural dynamics and physicochemical properties of pDNA/DODAB:MO lipoplexes: effect of pH and anionic lipids in inverted non-lamellar phases versus lamellar phases.Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.S4(13)-PV cell-penetrating peptide induces physical and morphological changes in membrane-mimetic lipid systems and cell membranes: implications for cell internalization.Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity.High-throughput microplate assay for the determination of drug partition coefficients.A biophysical approach to phospholipase A2 activity and inhibition by anti-inflammatory drugs.Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects.Biophysical characterization of the drug-membrane interactions: the case of propranolol and acebutolol.Partition and location of nimesulide in EPC liposomes: a spectrophotometric and fluorescence study.Differential interactions of rifabutin with human and bacterial membranes: implication for its therapeutic and toxic effects.Drug-membrane interaction studies applied to N'-acetyl-rifabutin.Sequential injection system for phospholipase A2 activity evaluation: studies on liposomes using an environment-sensitive fluorescent probe.The influence of rifabutin on human and bacterial membrane models: implications for its mechanism of action.Use of liposomes as membrane models to evaluate the contribution of drug-membrane interactions to antioxidant properties of etodolac.Effect of anti-inflammatory drugs on splenocyte membrane fluidity.Interaction of clonixin with EPC liposomes used as membrane models.Interactions of sulindac and its metabolites with phospholipid membranes: an explanation for the peroxidation protective effect of the bioactive metabolite.Effects of diclofenac on EPC liposome membrane properties.Binding of nonsteroidal anti-inflammatory drugs to DPPC: structure and thermodynamic aspects.The conformation of fusogenic B18 peptide in surfactant solutions.Lipid nanocarriers loaded with natural compounds: Potential new therapies for age related neurodegenerative diseases?Molecular interaction of Rifabutin on model lung surfactant monolayers.A reagent-free method based on a photo-induced fluorimetry in a sequential injection system.pH sensitive silica nanotubes as rationally designed vehicles for NSAIDs delivery.Synchrotron SAXS and WAXS study of the interactions of NSAIDs with lipid membranes.A Molecular Biophysical Approach to Diclofenac Topical Gastrointestinal DamageA biophysical approach to menadione membrane interactions: Relevance for menadione-induced mitochondria dysfunction and related deleterious/therapeutic effectsEffects of a novel antimycobacterial compound on the biophysical properties of a pulmonary surfactant model membraneInteraction of Celecoxib with Membranes: The Role of Membrane Biophysics on its Therapeutic and Toxic EffectsLipid–Drug Interaction: Biophysical Effects of Tolmetin on Membrane Mimetic Systems of Different DimensionalityNSAIDs Interactions with Membranes: A Biophysical ApproachAntioxidant Activity of Vitamin E and Trolox: Understanding of the Factors that Govern Lipid Peroxidation Studies In VitroEffect of anti-inflammatory drugs in phosphatidylcholine membranes: A fluorescence and calorimetric studyChanges in PLA2 activity after interacting with anti-inflammatory drugs and model membranes: evidence for the involvement of tryptophan residuesRole of counter-ion and helper lipid content in the design and properties of nanocarrier systems: a biophysical study in 2D and 3D lipid assemblies
P50
Q37441834-DC25CA2B-F70E-4FDC-8140-6A974923C8ACQ37719567-0E183D49-CCA6-45B3-A9D9-79392F28ABEDQ37976865-6DD6E6C3-F939-42D2-A19D-C4D9E0723AD5Q38847896-4EF445D4-E36B-4B11-B479-9A37A6A55D66Q38975384-B0800C4D-8CBC-45FC-9ED0-CDA1B4B70AA1Q38979851-EE2338F3-BD35-44DF-88C2-DEE32AB60CF0Q39102128-891285B5-8281-4E67-B64D-CC2C1E758251Q39666244-CC32795B-1D37-45EB-9212-8CAD11BFBBD6Q40054771-4AF228D7-31D2-4D92-9EFA-A11F91AE6974Q42844147-DD99A9CB-3FE9-41B5-8D4D-C015BA42C93FQ42905542-0A119019-57A8-4DF1-B3A1-489D8F307978Q42944153-6DEDC168-DEF5-4CC6-A9A1-89C694D30D05Q44374555-432A1BB9-9112-443B-ABA1-944936E75B8EQ44536436-27864443-3B70-4B18-9C32-1C6E58BF1317Q44785648-034D94C5-8EA9-4733-9014-2FBBA4D13933Q45836607-F9A917EA-A87C-47E3-8AB8-441FCD65F321Q45926296-F422842C-271D-4C9A-A6ED-827730ED59C5Q46082374-AE142E12-B63E-41D7-8795-2A804EE356DBQ46364025-6801D842-1DDD-44D4-A769-31D50144F81CQ46377689-D8561486-1C3F-4DEC-94D1-23CDE0F43C59Q46461601-6D0F6E7F-CEC7-47E2-BD7A-83486535E3F1Q46463065-D8B75DDB-87B9-4782-9F97-60FC247A3775Q46571084-8B3E8FAC-A810-4DCC-9765-3732CFCB0F53Q46706117-F6F26038-D02A-422D-B81C-B83FDEBCA6DFQ50867920-9AFEDC25-5E60-46F0-94DE-F4065F825D93Q52593939-E2143C82-C04C-4A18-ACFE-B0AB55A2DAB1Q52629152-C6FE5A13-A4D8-455B-A4FE-68E171FFE93AQ53221022-AD8C0429-2718-4BE1-AF7D-571CB6BA7808Q53721756-26DDA626-CC9E-4A8C-ADD6-5ECAEFD44DC9Q54138402-4708C7E9-3056-41ED-9860-A041602009CFQ58584850-EA238467-4E36-42FA-9E2C-D10057C7CF55Q59163797-80740E63-FEB3-4D80-8233-C3E5B50312E2Q59163800-6868C129-BB00-4683-BF95-AB30B5802916Q59163812-C2E0966E-C38B-4D0E-A5E4-55B8D8D7DC6FQ59163818-ED360450-DEE8-4559-9469-F1C092ACA129Q59163820-A75E38F4-9581-4B17-8768-B1462F18701BQ59163825-B3E2911F-6651-4C9D-A435-2B193B89B6E9Q59163827-B7D918AA-E57E-4BE5-AA99-FDD40A853035Q59569455-5C57DFD6-CED7-43A9-89EC-887C9C32F329Q60187594-FC0C6258-9A63-49E1-8642-85EAFD2C783C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marlene Lúcio
@ast
Marlene Lúcio
@en
Marlene Lúcio
@es
Marlene Lúcio
@nl
Marlene Lúcio
@sl
type
label
Marlene Lúcio
@ast
Marlene Lúcio
@en
Marlene Lúcio
@es
Marlene Lúcio
@nl
Marlene Lúcio
@sl
altLabel
M Lucio
@en
M Lúcio
@en
Marlene Lúcio
@en
prefLabel
Marlene Lúcio
@ast
Marlene Lúcio
@en
Marlene Lúcio
@es
Marlene Lúcio
@nl
Marlene Lúcio
@sl
P1053
L-3306-2014
P106
P1153
24070869000
P21
P31
P3829
P496
0000-0003-2593-1672